Author(s): Vijayasankari A, Indra S, Kalpana T and Kalpana S
Abstract: The newest member of the coronavirus family (2019- nCoV) has been recently identified that results in acute and severe respiratory syndrome in humans. The first infected patient who had clinical manifestations such as fever, cough, and dyspnea was reported on 12 December 2019 in Wuhan, China. In-vitro studies have shown that chloroquine is effective against several viruses, including severe acute respiratory syndrome coronavirus (SARS-CoV). Multiple mechanisms of action have been identified for chloroquine that disrupt the early stage of coronavirus replication. The use of homeopathy for epidemic diseases dates back to the time of Hahnemann, who recommended Belladonna for scarlet fever. It is interesting to note that homeopathy was invented in the same year as Jenner first practiced vaccination (1796) and that Hahnemann strongly favored vaccination. The AYUSH ministry issued a health advisory and recommended that homeopathic and unani medicines could be effective in the prevention of novel coronavirus (nCoV) infections.